Table 4 Medications used during hospitalization
From: Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital
All patients | Recovery group | Non-recovery group | p value | |
|---|---|---|---|---|
(N = 143) | (N = 130) | (N = 13) | ||
RAAS inhibitors, No (%) | 16 (11.2) | 14 (10.8) | 2 (15.4) | 0.641 |
Antibiotics, No (%) | 125 (87.4) | 115 (88.5) | 10 (76.9) | 0.212 |
Antivirus, No (%) | 136 (95.1) | 123 (94.6) | 13 (100.0) | > 0.999 |
Antidiabetic, No (%) | 37 (25.9) | 35 (26.9) | 2 (15.4) | 0.515 |
Diuretic, No (%) | 18 (12.6) | 18 (13.8) | 0 (0.0) | 0.372 |
Glucocorticoid, No (%) | 83 (58.0) | 77 (59.2) | 6 (46.2) | 0.390 |